Medreich Limited Naproxen Export Data — India (DGFT 2022–2026)

Name: Medreich Limited Naproxen Export Records India — #14 Exporter, 101 Shipments, $1.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Naproxen

India Pharmaceutical Trade Intelligence

$133.8M192 Suppliers76 CountriesHS 30049069

ExportsIndia → UNITED STATES42.1%India → CANADA21.1%

ImportsUNITED STATES → India$391.7K GERMANY → India$185.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Medreich Limited — Naproxen Exporter #14 | $1.9M Trade Value | TransData Nexus | TransData Nexus

Medreich Limited — Naproxen Exporter Profile

Indian Pharmaceutical Exporter · #14 for Naproxen · $1.9M export value · DGFT Verified

Medreich Limited is the #14 Indian exporter of Naproxen with $1.9M in export value and 101 verified shipments. Medreich Limited holds a 1.4% market share in Naproxen exports across 4 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.

Medreich Limited — Naproxen Export Profile: Buyers & Destinations

Medreich Limited Naproxen export treemap — buyers and destination countries | TransData Nexus

Where Does Medreich Limited Export Naproxen?

Country	Value	Shipments	Share
SWEDEN	$850.2K	53	46.7%
UNITED KINGDOM	$700.2K	30	38.4%
UNITED ARAB EMIRATES	$140.8K	9	7.7%
IRELAND	$130.8K	9	7.2%

Who Are the Top Buyers of Naproxen from Medreich Limited?

Buyer	Country	Value	Orders
MEDREICH PLC	UNITED KINGDOM	$700.2K	30
DHL EXEL SUPPLY CHAIN (SWEDEN) AB	SWEDEN	$575.4K	30
DHL EXEL SUPPLY CHAIN SWEDEN AB	SWEDEN	$274.8K	23
LIFEPHARMA FZE	UNITED ARAB EMIRATES	$140.8K	9
AZURE PHARMACETICALS	IRELAND	$99.6K	8
AZURE PHARMACEUTICALS	IRELAND	$31.1K	1

Medreich Limited supplies Naproxen to 6 buyers globally. The largest buyer is MEDREICH PLC (UNITED KINGDOM), followed by DHL EXEL SUPPLY CHAIN (SWEDEN) AB (SWEDEN) and DHL EXEL SUPPLY CHAIN SWEDEN AB (SWEDEN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Naproxen Formulations Does Medreich Limited Export?

Product Description / Formulation	Value	Shipments
NAPROXEN 250MG TABLETS (NAPROXEN BLUEFIS	$133.8K	9
NAPROXEN 500MG TABLETS (NAPROXEN BLUEFIS	$129.1K	4
NAPROXEN 250MG GASTRO-RESISTANT TABLETS	$116.3K	4
NAPROXEN 500MG GASTRO-RESISTANT TABLETS	$84.2K	3
NAPROXEN TABLETS 500MG 2X14S (84030 PA	$50.0K	1
NAPROXEN TABLETS 500MG 2X14S 83400PACKS	$50.0K	1
NAPROXEN 500MG TABLETS (NAPROXEN BLUEFISH 500MG TABLETS) 10X10S (21241 PACKS)	$50.0K	1
NAPROXEN 500MG GASTRO-RESISTANT TABLETS(PROXLIFE GASTRO RESISTANT TABLETS 500MG) 50X10S (1000 PACKS)	$46.9K	2
NAPROXEN 500MG TABLETS (NAPROXEN BLUEFISH 500MG TABLETS) 10X10S (12204 PACKS)	$45.7K	1
NAPROXEN 500MG TABLETS NAPROXEN BLUEFISH 500MG TABLETS 10X10S 12204 PACKS	$45.6K	1

Medreich Limited exports 71 distinct Naproxen formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NAPROXEN 250MG TABLETS (NAPROXEN BLUEFIS with 9 shipments worth $133.8K.

How Does Medreich Limited Compare to Nearest Naproxen Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MYLAN LABORATORIES LIMITED	$2.8M	55	3	$50.0K
13	FOURRTS I LABORATORIES PRIVATE LIMITED	$1.9M	47	2	$41.3K
14	MEDREICH LIMITED ★	$1.9M	101	4	$18.8K
15	S KANT HEALTHCARE LIMITED	$1.6M	36	1	$45.7K
12	DR REDDYS LABORATORIES LIMITED	$900.0K	18	1	$50.0K

Medreich Limited ranks #14 among 192 Indian Naproxen exporters. Average shipment value of $18.8K compared to the market average of $405.2K. The closest competitors by value are MYLAN LABORATORIES LIMITED and FOURRTS I LABORATORIES PRIVATE LIMITED.

Which Indian Ports Ship Naproxen Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	429	12.6%
SAHAR AIR CARGO ACC (INBOM4)	245	7.2%
SAHAR AIR	236	6.9%
DELHI AIR CARGO ACC (INDEL4)	211	6.2%
JNPT/ NHAVA SHEVA SEA	156	4.6%
HYDERABAD ICD	145	4.2%
VIZAG SEA	140	4.1%
BANGALORE AIR	128	3.7%

Geopolitical & Trade Policy Impact on Medreich Limited's Naproxen Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)

Medreich Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)

For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Naproxen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 101 individual customs records matching Medreich Limited exporting Naproxen, covering 71 formulations to 4 countries via 6 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 76+ countries, 366+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Naproxen

Naproxen

Medreich Limited — Naproxen Exporter Profile

Medreich Limited — Naproxen Export Profile: Buyers & Destinations

Where Does Medreich Limited Export Naproxen?

Who Are the Top Buyers of Naproxen from Medreich Limited?

What Is India's Total Naproxen Export Value and How Much Does Medreich Limited Contribute?

What Is the Average Shipment Value for Medreich Limited's Naproxen Exports?

How Does Medreich Limited Compare to Other Indian Naproxen Exporters?

What Naproxen Formulations Does Medreich Limited Export?

Regulatory Requirements: Exporting Naproxen to Key Markets

United Kingdom — MHRA

How Does Medreich Limited Compare to Nearest Naproxen Exporters?

Which Indian Ports Ship Naproxen Exports?

What Other Analgesics & Antipyretics Products Does Medreich Limited Export?

Geopolitical & Trade Policy Impact on Medreich Limited's Naproxen Exports

Medreich Limited — Regulatory Compliance & Quality Standards

About Medreich Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Naproxen Export Data from Medreich Limited

Naproxen Stats

Company Overview

Top Products by Medreich Limited

Related Analysis

Need Detailed Export Data?

Data Source